David A. Siegel Horizon Therapeutics Public LTD CO Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $28.9 Million - $33.7 Million	-291,600 Reduced 89.42%	34,500 $3.99 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $4.46 Million - $5.2 Million	46,300 Added 16.55%	326,100 $33.5 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $13 Million - $13.8 Million	121,500 Added 76.75%	279,800 $30.5 Million
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $13.6 Million - $24.9 Million	-218,600 Reduced 58.0%	158,300 $18 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $21.5 Million - $30.9 Million	364,400 Added 2915.2%	376,900 $23.3 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $992,500 - $1.45 Million	12,500 New	12,500 $997,000
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $959,262 - $1.22 Million	-11,100 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $1.09 Million - $1.33 Million	11,100 New	11,100 $1.2 Million
Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $5.4 Million - $6 Million	-62,600 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $31.7 Million - $42.1 Million	-440,900 Reduced 87.57%	62,600 $5.76 Million
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $2.52 Million - $3.17 Million	37,600 Added 8.07%	503,500 $36.8 Million
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $4.19 Million - $6.07 Million	75,898 Added 19.46%	465,900 $36.2 Million
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $524,664 - $989,913	17,373 Added 4.66%	390,002 $21.7 Million
Q1 2020 May 15, 2020	SELL	$24.87 - $38.56 $11.1 Million - $17.2 Million	-445,500 Reduced 54.45%	372,629 $11 Million
Q4 2019 Feb 14, 2020	BUY	$25.43 - $36.67 $38,145 - $55,005	1,500 Added 0.18%	818,129 $29.6 Million
Q3 2019 Nov 14, 2019	SELL	$23.0 - $27.97 $5.97 Million - $7.26 Million	-259,500 Reduced 24.11%	816,629 $22.2 Million
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $24.5 Million - $30.6 Million	1,076,129 New	1,076,129 $25.9 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account